ClinicalTrials.gg
Sign In

Nasopharyngeal Carcinoma clinical trials

The registry lists 683 studies for Nasopharyngeal Carcinoma across more than 10 countries. 270 are recruiting or about to start. 612 of them are mainly about Nasopharyngeal Carcinoma (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13.

ClinicalTrials.gov finds 1,138 studies for Nasopharyngeal Carcinoma. How that becomes 681 here

This page counts the studies the registry files under Nasopharyngeal Carcinoma, and those it files under no condition that list Nasopharyngeal Carcinomathemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,138Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −4List Nasopharyngeal Carcinoma as a condition, but the registry did not file them under itMost often written as “Can Undertake Nasopharyngeal Carcinoma Specimens in the Materia，” (1), “Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma Diagnosis” (1), and “Otitis Media With Effusion After Nasopharyngeal Carcinoma” (1). The registry filed them under other conditions only, most often Nasopharyngeal Neoplasms (2) and Deglutition Disorders (1).
  3. −453Match it another way128 name it in the title and 325 by a synonym or other text the search reads.
  4. 681The count on this page32 of them list Nasopharyngeal Carcinoma in their own words; the registry filed them under no condition.

Get an email when these change. Save the Nasopharyngeal Carcinoma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Recruiting
186
Status unknown
172
Completed
136
Not yet recruiting
83
Active, not recruiting
66
Terminated
28

Phase

Phase 2
294
Phase 3
149
Phase 1
80
Early Phase 1
7
Phase 4
4

Where

China
489
United States
59
Singapore
34
Taiwan
31
Hong Kong
19
Canada
11

Who runs them

Sun Yat-sen University (186) · Fudan University (26) · Zhejiang Cancer Hospital (23) · Fujian Cancer Hospital (21) · Jiangxi Provincial Cancer Hospital (14) · National Cancer Institute (NCI) (13) · Ming-Yuan Chen (10) · Eye & ENT Hospital of Fudan University (9)

What is being tested here

Drugs under test in Nasopharyngeal Carcinoma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Toripalimab21734
Gemcitabine101225
Cisplatin91744
Camrelizumab9317
Becotatug vedotin829
Nimotuzumab7517
Capecitabine6917
Tislelizumab538
Sintilimab417
Izalontamab brengitecan425

Drug classes tested here Immune checkpoint inhibitors 68 open · Antimetabolites 19 open · Tyrosine kinase inhibitors (TKIs) 6 open · Angiogenesis inhibitors 5 open · Antimitotic agents 4 open

Coming up

96phase 3 studies under way
64studies finish main data collection within a year19 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 186 Nasopharyngeal Carcinoma studies recruiting now, 42 (23%) set no upper age limit and 135 (73%) stop at 75 or younger. 9 (5%) take children under 18. 0 (0%) are for women only and 2 (1%) for men only; 8 (4%) take healthy volunteers.

Recruiting studies that take each age, of 186
AgeWomenMen
109 (5%)9 (5%)
18175 (94%)176 (95%)
30180 (97%)182 (98%)
40181 (97%)183 (98%)
50181 (97%)183 (98%)
65177 (95%)178 (96%)
7583 (45%)84 (45%)
8546 (25%)47 (25%)

Across all 683 studies, recruiting or not: 68% stop at 75 or younger and 22% at 65; 9% take children; <1% are for women only and 1% for men only; 5% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Nasopharyngeal Carcinoma studies take

Of 143 phase 2 interventional studies under Nasopharyngeal Carcinoma, half reached primary completion within 43 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 147 mo37–75 · 28 studies——
Phase 243 mo28–65 · 143 studies—49 mo31–74 · 128 studies
Phase 369 mo51–82 · 84 studies——
Interventional, no phase45 mo22–… · 49 studies——
Observational55 mo36–155 · 52 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 15, 2026.

Started recruiting4

Newly registered6

Show 1 more

Studies

Recruiting first, then most recently updated. Showing 50 of 683. Browse all 683 → or search them.